|
|||||
|
|
Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage |
|
| Authors: | Vestal Mark L. Hodulik Kimberly Mando-Vandrick Jennifer James Michael L. Ortel Thomas L. Fuller Matthew Notini Maria Friedland Mark Welsby Ian J. |
| Affiliation: | 1.Department of Pharmacy, Duke University Medical Center, Durham, NC, USA ;2.Department of Pharmacy, Duke Regional Hospital, 3643 North Roxboro Street, Durham, NC, 27704, USA ;3.Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA ;4.Department of Neurology, Duke University Medical Center, Durham, NC, USA ;5.Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, NC, USA ;6.Clincial Laboratories, Duke University Medical Center, Durham, NC, USA ; |
| Abstract: | Journal of Thrombosis and Thrombolysis - Limited data exists regarding the clinical outcomes of andexanet alfa and four factor prothrombin complex concentrate (4F-PCC) for reversal of apixaban or... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |